Boothbay Fund Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-44,909
Closed -$74.1K 1615
2024
Q3
$74.1K Hold
44,909
﹤0.01% 1480
2024
Q2
$99.7K Sell
44,909
-2,462
-5% -$5.79K ﹤0.01% 1351
2024
Q1
$127K Sell
47,371
-49,362
-51% -$120K ﹤0.01% 1394
2023
Q4
$289K Sell
96,733
-269,565
-74% -$350K 0.01% 1200
2023
Q3
$359K Buy
366,298
+32,031
+10% +$46.3K 0.01% 1184
2023
Q2
$465K Buy
334,267
+70,175
+27% +$98K 0.01% 1128
2023
Q1
$420K Buy
264,092
+30,657
+13% +$158K 0.01% 1326
2022
Q4
$1.45M Sell
233,435
-29,623
-11% -$212K 0.03% 737
2022
Q3
$1.76M Sell
263,058
-8,485
-3% -$58.3K 0.04% 629
2022
Q2
$1.73M Buy
+271,543
New +$1.54M 0.05% 604

Other funds holding ESPR